Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on May 07, 2026.
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts more than Nifty Smallcap 250 and 4.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Diagnostic Centre Limited's Board approved audited financial results for Q4 and FY 2026 (figures not disclosed in filing) and recommended a final dividend of ₹2 per share (200% on ₹1 face value), subject to shareholder approval at the upcoming AGM. The Board granted 1,79,500 ESOPs to eligible employees at ₹784 per option (20% discount on 3-month average price), vesting over 1-4 years based on time and performance criteria. Dr. D Nageshwar Reddy will not seek re-appointment as Independent Director from May 25, 2026 due to other commitments. The company also approved acquisition of MRI, EEG and NCV Services Business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore in cash, expected to complete within 3 months.
Dividend recommendation signals stable cash generation. ESOP grant aligns employee interests with shareholders. Loss of independent director requires board reconstitution. The subsidiary acquisition consolidates diagnostic services under the parent company, potentially improving operational synergies.